APA
Verburg F. A., Giovanella L., Iakovou I., Konijnenberg M. W., Langsteger W., Lassmann M., Mihailovic J. & Luster M. (20181217). I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?. : European journal of nuclear medicine and molecular imaging.
Chicago
Verburg Frederik A, Giovanella Luca, Iakovou Ioannis, Konijnenberg Mark W, Langsteger Werner, Lassmann Michael, Mihailovic Jasna and Luster Markus. 20181217. I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?. : European journal of nuclear medicine and molecular imaging.
Harvard
Verburg F. A., Giovanella L., Iakovou I., Konijnenberg M. W., Langsteger W., Lassmann M., Mihailovic J. and Luster M. (20181217). I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?. : European journal of nuclear medicine and molecular imaging.
MLA
Verburg Frederik A, Giovanella Luca, Iakovou Ioannis, Konijnenberg Mark W, Langsteger Werner, Lassmann Michael, Mihailovic Jasna and Luster Markus. I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?. : European journal of nuclear medicine and molecular imaging. 20181217.